HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel. (Q45165295)
Jump to navigation
Jump to search
scientific article published in August 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel. |
scientific article published in August 2004 |
Statements
HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel (English)
S Chan
M Paesmans
K Friedrichs
T Pinter
V Cocquyt
E Murray
I Bodrogi
B Lesperance
S Korec
J Crown
P Simmonds
J Y Leroy
V Durbecq
J Isola
M Aapro
M J Piccart
1 reference